Fast on the heels of a $806.4 million stock sale, Waltham-based diagnostics maker Inverness Medical Innovations (AMEX: [[ticker:IMA]]) today announced it has agreed to acquire Upper Saddle River, NJ-based ParadigmHealth for roughly $230 million in cash. Bent on growth, Inverness has already announced about a dozen acquisitions this year alone.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
